TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Fractyl Health Reports Positive 6-Month REVEAL-1 Open-Label Results Showing Sustained Post-GLP-1 Weight Maintenance After a Single Revita® Procedure

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Fractyl Health
Fractyl Health Reports Positive 6-Month REVEAL-1 Open-Label Results Showing Sustained Post-GLP-1 Weight Maintenance After a Single Revita® Procedure

Fractyl Health reported positive 6-month clinical results showing patients maintained stable weight after a single Revita procedure following GLP-1 drug discontinuation, with minimal weight change and promising metabolic control.

Insights
FpC   negative

Mentioned as a rival potentially hurt by changes in EV market incentives


GUTS   positive

Demonstrated promising clinical results with Revita procedure, showing sustained weight maintenance and metabolic stability after GLP-1 drug discontinuation, with no serious adverse events and potential for future regulatory approval